Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria V Guijarro

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Plos One|January 26, 2023
MiR-130b modulates the invasive, migratory, and metastatic behavior of leiomyosarcomaLaura S Danielson, Maria V Guijarro, Silvia Menendez, et al.
Iscience|December 9, 2025
Integrated proteomic analysis identifies TYMS-dependent AMPK-mTOR signaling in pancreatic neuroendocrine tumorsVinod Vijayakurup, Benjamin Meyer, Syeda Rida Rizvi, et al.
The American Journal of Pathology|June 19, 2010
A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancyLaura S Danielson, Silvia Menendez, Camille Stephan-Otto Attolini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 29, 2012
Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesisLaura S Danielson, David S Park, Noemi Rotllan, et al.
Carcinogenesis|April 12, 2007
MAP17 overexpression is a common characteristic of carcinomasMaria V Guijarro, Juan F M Leal, Jesus Fominaya, et al.
Leukemia Research|January 19, 2015
Limited miR-17-92 overexpression drives hematologic malignanciesLaura S Danielson, Linsey Reavie, Marc Coussens, et al.
The American Journal of Pathology|May 28, 2013
Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signalingMaria V Guijarro, Sonika Dahiya, Laura S Danielson, et al.
JCI Insight|September 1, 2022
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survivalVinod Vijayakurup, Kyungah Maeng, Hye Seung Lee, et al.
Cell|June 17, 2008
Chemokine signaling via the CXCR2 receptor reinforces senescenceJuan C Acosta, Ana O'Loghlen, Ana Banito, et al.
The Journal of Clinical Investigation|April 30, 2019
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survivalPatrick Kellish, Daniil Shabashvili, Masmudur M Rahman, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Plos One|January 26, 2023
MiR-130b modulates the invasive, migratory, and metastatic behavior of leiomyosarcomaLaura S Danielson, Maria V Guijarro, Silvia Menendez, et al.
Iscience|December 9, 2025
Integrated proteomic analysis identifies TYMS-dependent AMPK-mTOR signaling in pancreatic neuroendocrine tumorsVinod Vijayakurup, Benjamin Meyer, Syeda Rida Rizvi, et al.
The American Journal of Pathology|June 19, 2010
A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancyLaura S Danielson, Silvia Menendez, Camille Stephan-Otto Attolini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 29, 2012
Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesisLaura S Danielson, David S Park, Noemi Rotllan, et al.
Carcinogenesis|April 12, 2007
MAP17 overexpression is a common characteristic of carcinomasMaria V Guijarro, Juan F M Leal, Jesus Fominaya, et al.
Leukemia Research|January 19, 2015
Limited miR-17-92 overexpression drives hematologic malignanciesLaura S Danielson, Linsey Reavie, Marc Coussens, et al.
The American Journal of Pathology|May 28, 2013
Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signalingMaria V Guijarro, Sonika Dahiya, Laura S Danielson, et al.
JCI Insight|September 1, 2022
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survivalVinod Vijayakurup, Kyungah Maeng, Hye Seung Lee, et al.
Cell|June 17, 2008
Chemokine signaling via the CXCR2 receptor reinforces senescenceJuan C Acosta, Ana O'Loghlen, Ana Banito, et al.
The Journal of Clinical Investigation|April 30, 2019
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survivalPatrick Kellish, Daniil Shabashvili, Masmudur M Rahman, et al.
Pageof 3